PRISCILA GOMEZ: Open Payments
NPI 1316687981 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 46 payments from 10 companies in 2025. Trend: 2023 $343 · 2024 $785 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $264 |
| Abbott Laboratories | 6 | $159 |
| Novo Nordisk Inc | 11 | $141 |
| ABBVIE INC. | 6 | $131 |
| PFIZER INC. | 3 | $77 |
| Exact Sciences Corporation | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, ZEPBOUND, MOUNJARO, ELIQUIS, Cologuard Collection Kit, Wegovy, JARDIANCE, UBRELVY.
Industry payments across TX — which companies pay providers there.
